Testing a new gel for moderate to severe melasma
Part of Skin clinical trials.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old with moderate to severe melasma that has been stable for at least 3 months.
- You must be willing to apply a study gel to your face and use only the provided sunscreen, moisturizer, and cleanser.
- You need to stop using other skin-lightening or anti-aging creams for the duration of the study.
- Women who can become pregnant must use reliable birth control (like pills, IUD, or abstinence) and not change it during the study.
- You should avoid excessive sun exposure and tanning, and you must apply the study sunscreen daily.
- You cannot have other skin conditions (like eczema, psoriasis, or vitiligo) on your face, or have used certain treatments (like lasers, peels, or bleaching creams) recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called Secretome TGF Beta 3 for women with melasma. It aims to see if this treatment can improve dark patches on the skin.
This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.
This trial tests a new gel containing three active ingredients to treat melasma, a condition that causes dark patches on the skin, usually on the face. The gel is applied to the skin and may help reduce discoloration and improve skin appearance.
This trial tests if adding a special serum to laser treatment can better treat dark spots from acne and melasma in women with medium to dark skin tones. The serum contains ingredients that may help lighten spots and improve skin tone.
This trial tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for treating dark spots caused by melasma, acne scars, or sun damage. It may be a good option if you have mild to moderate dark spots and are willing to avoid sun exposure and other skin-lightening products.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.